Preparing for the New Era of Blood-Based Biomarkers in Alzheimer’s Disease: Navigating Guidelines, Understanding Policy, and Integrating Into Practice Workflows

Practice Gap: Underdiagnosis of AD in the early stages of the disease (eg, MCI or mild dementia due to AD), with diagnosis often delayed by 2–3 years and up to 90% of patients with MCI remaining undiagnosed or incorrectly diagnosed…